<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: aids treatment</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'aids treatment'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22aids+treatment%22&t=%22aids+treatment%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:38:19 +0100</lastBuildDate>
        <item>
            <title>AIDS Action Committee Encouraged By New Pre-Exposure Prophylaxis Study</title>
            <link>http://www.medworm.com/index.php?rid=4197298&amp;cid=t_138509_135_f&amp;fid=35277&amp;url=http%3A%2F%2Fblog.aac.org%2Findex.php%2F2010%2F11%2F23%2Faids-action-committee-encouraged-by-new-pre-exposure-prophylaxis-study%2F</link>
            <description>BOSTON, November 23, 2010—Results published today from a National Institute of Health clinical trial shows that taking a once-a-day anti-HIV pill  can reduce the risk of HIV infection by 44 percent in gay and bisexual men, transgender women who have sex with men.
Half of the participants in the clinical trial were given a daily pill containing two anti-retroviral drugs (ARVs), emtricitabine and tenofovir. Both drugs are already widely available in the ARV combination pill Truvada, which is commonly prescribed in HIV treatment. The other half of the trial participants were given a placebo pill.
Participants were tested for HIV monthly, and received risk-reduction counseling, condoms, and management of any sexually-transmitted infections. During the trial period, 64 people in the placebo ...</description>
            <author>AIDS Action Committee's Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4197298</comments>
            <pubDate>Tue, 23 Nov 2010 21:56:29 +0100</pubDate>
            <guid isPermaLink="false">4197298</guid>        </item>
        <item>
            <title>Bone Marrow Transplant Cured AIDS?</title>
            <link>http://www.medworm.com/index.php?rid=1960816&amp;cid=t_138509_87_f&amp;fid=35052&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FWomensBioethicsBlog%2F%7E3%2F451973805%2Fbone-marrow-transplant-cured-aids.html</link>
            <description>BBC News reports that a patient suffering from AIDS and leukemia shows no signs of AIDS infection after receiving a bone marrow transplant from an AIDS-resistant donor. He had been infected with the human immunodeficiency virus, that causes Aids, for more than a decade and also had leukaemia.The clinic said since the transplant was carried out 20 months ago, tests on the patient's bone marrow, blood and other organ tissues have all been clear.In a statement, Professor Rodolf Tauber from the Charite clinic said: &quot;This is an interesting case for research.&quot;But to promise to millions of people infected with HIV that there is hope of a cure would not be right.&quot; Like many of you, I am skeptical about the long-term efficacy of this treatment and am concerned about the social justice challenges pr...</description>
            <author>Women's Bioethics Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1960816</comments>
            <pubDate>Thu, 13 Nov 2008 16:54:28 +0100</pubDate>
            <guid isPermaLink="false">1960816</guid>        </item>
        <item>
            <title>HIV Preventative Significant Boost for Women</title>
            <link>http://www.medworm.com/index.php?rid=1255108&amp;cid=t_138509_87_f&amp;fid=35052&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FWomensBioethicsBlog%2F%7E3%2F241072280%2Fhiv-preventative-significant-boost-for.html</link>
            <description>Researchers at the University of Alabama (UAB) and the University of Pittsburgh School of Medicine say an experimental anti-HIV gel being tested in Phase II trial studies is safe for women to use on...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]] (Source: Women's Bioethics Blog)</description>
            <author>Women's Bioethics Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1255108</comments>
            <pubDate>Mon, 25 Feb 2008 20:12:04 +0100</pubDate>
            <guid isPermaLink="false">1255108</guid>        </item>
        <item>
            <title>Bristol-Myers Slammed By AIDS Group Over Pricing</title>
            <link>http://www.medworm.com/index.php?rid=1156046&amp;cid=t_138509_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F217605830%2F</link>
            <description>The Fair Pricing Coalition, an independent community group that works to contain the prices of drugs used to treat HIV, is condemning price increases announced this week by Bristol-Myers Squibb, which failed to meet with the umbrella group, as most other drugmakers do, to discuss pricing.
The increases, which ranged from 6.9 percent to 9 percent for all of Bristol’s HIV products “are well beyond any increases in the Consumer Price Index and above the increases taken by any other company”, says Martin Delaney of the FPC, in a statement. “These drugs have been on the market for several years and their development costs have long been recovered. There is no justification for this kind of increase.”
Another FPC spokesperson, Lynda Dee of the AIDS Treatment Activist Coalition and AIDS...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1156046</comments>
            <pubDate>Wed, 16 Jan 2008 12:20:02 +0100</pubDate>
            <guid isPermaLink="false">1156046</guid>        </item>
        <item>
            <title>HIV/AIDS Treatment Forum at Duke University Medical Center</title>
            <link>http://www.medworm.com/index.php?rid=790577&amp;cid=t_138509_135_f&amp;fid=35263&amp;url=http%3A%2F%2Fronhudson.blogspot.com%2F2007%2F08%2Fblog-post_5142.html</link>
            <description>The Community Advisory Board and Staff of the Duke University AIDS Research and Treatment Center are hosting a forum on 22 August, 2007. This forum is to provide an update from this year's International Conference on AIDS and to discuss issues relating to HIV and aging.I know that there are many long-term survivors worldwide who are seeking answers about their specific issues as they continue to face emerging side-effects and disease progression. If anyone has questions that they would like me to ask at this forum, I will do so. Simply email me your questions and I will compile a list for the panel.Please note that the area code for the number to RSVP is 919. Click the invitation to enlarge it for reading. Categories: HIV AIDS HIV/AIDS Duke+University AIDS+Research AIDS+treatment Community...</description>
            <author>2sides2ron</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=790577</comments>
            <pubDate>Thu, 09 Aug 2007 15:34:00 +0100</pubDate>
            <guid isPermaLink="false">790577</guid>        </item>
    </channel>
</rss>

